Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2011 , Vol 53 , Num 3
FORMULATION AND EVALUATIONS OF EZETIMIBE NANOPARTICLES PREPARED BY CONTROLLED NANOPRECIPITATION AND TRANSFORMATION INTO SOLID DOSAGE FORM
VİKRAM PANDYA, JAYVADAN PATEL
Department of pharmaceutics, B.S.Patel Pharmacy college,Linch, Gujarat, India

Summary

Istanbul Medipol University